)
Visual
test
VentriPoint Diagnostics
VentriPoint Diagnostics (VPT) investor relations material
VentriPoint Diagnostics Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary28 Nov, 2025
Executive summary
Focused on commercializing VMS+ cardiac diagnostic platform, with direct sales in North America and hybrid models in Europe and the UK.
Achieved regulatory milestones: FDA 510(k) clearance, EU CE-Mark, and Health Canada approval for VMS+ V4.0.
Expanded commercial operations, upgraded customer sites, and signed key collaboration agreements.
Installed new systems and upgraded existing ones, with a growing installed base in the US, Europe, and UK.
Financial highlights
Revenue for Q3 2025 was $104,304, up from $64,507 in Q3 2024; nine-month revenue was $175,624, up from $95,172 year-over-year.
Net loss for Q3 2025 was $752,084, improved from $1,251,079 in Q3 2024; nine-month net loss was $3,000,491, improved from $3,859,958 year-over-year.
Operating expenses for Q3 2025 were $750,263, down from $1,258,517 in Q3 2024; nine-month operating expenses were $2,836,523, down from $3,845,524 year-over-year.
Cash used in operating activities for nine months was $955,549, down from $2,665,385 year-over-year.
Cash provided by financing activities was $944,081 for nine months, down from $1,492,958 year-over-year.
Cash and cash equivalents at September 30, 2025, were $68,322.
Outlook and guidance
Plans to raise approximately $500,000 by year-end 2025 to support ongoing operations.
Management confident in ability to secure additional capital with continued support from advisors, shareholders, and improving equity markets.
Focus remains on scaling commercial operations and expanding market presence.
Update on $5M capital raise plan.
VMS+ new system installs YTD 2025?
Rationale for related party debenture conversions?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 7 FebSBIN
Q3 FY26 net profit reached ₹21,028.15 crore, driven by robust income and strategic divestments. - 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus. - 6 FebWEC
Targets 7–8% EPS growth, $37.5B capex, and coal exit by 2032 amid surging data center demand. - 6 FebBR
Q2 FY26 recurring revenue grew 8% and adjusted EPS guidance was raised to 9-12%. - 6 FebFFWM
Merger vote includes new non-voting stock class with limited conversion and no voting rights. - 6 FebKKR
Charter amendments seek to modernize governance and establish one share, one vote by 2026. - 6 FebARI
Proposed $9B real estate loan portfolio acquisition highlights disciplined, long-term strategy. - 6 FebSMCI
Q2 revenue jumped 123% to $12.7B, with FY26 guidance raised to at least $40B. - 6 FebRJF
Record revenues and assets, higher dividend, and acquisitions despite lower net income.
Next VentriPoint Diagnostics earnings date
Q4 202530 Apr, 2026
VentriPoint Diagnostics
Next VentriPoint Diagnostics earnings date
Q4 202530 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
VentriPoint Diagnostics Ltd. is a Canadian medical device company specializing in the development and commercialization of innovative cardiac diagnostic tools. Their flagship product, the VentriPoint Medical System (VMS+), represents a significant advancement in heart imaging technology. VMS+ is designed to provide a detailed 3D visualization of the heart's structure and function without the need for magnetic resonance imaging (MRI). This system enhances ultrasound capabilities, offering a cost-effective, fast, and accurate diagnostic solution that enables the analysis of all four heart chambers, with a particular focus on the right ventricle, which is challenging to image using conventional methods. The technology's proprietary Knowledge Based Reconstruction (KBR) technology facilitates the creation of 3D heart models and calculates volumes and ejection fractions with accuracy comparable to MRI standards. The company is headquartered in Toronto, Canada, and its shares are listed on the TSX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage